C
Checkpoint Therapeutics D
D
CKPT
4.05000
USD
0.00
(0.00%)
قبل الجلسة
حجم التداول
22
الربح لكل سهم
0
العائد الربحي
-
P/E
-3
حجم السوق
339,243,119
الأخبار المقالات
العنوان: Checkpoint Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patientswith solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.